How did Zoetis' revenue and expenses trend in Q4 2024?

Zoetis' revenue and expenses in Q4 2024 showed a notable trend with the company reporting $80 million in revenue from its Contract Manufacturing business. However, the net income for the period was $581 million, which suggests that despite the revenue being generated from a specific business segment, the overall financial performance of the company was positive, with operating expenses being $581 million.

|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|ZTS|ZTS.N|Zoetis|20240101-2024|Contract Manufacturing|8.0E7|169|
|ZTS|ZTS.N|Zoetis|20240101-2024|Contract Manufacturing|5.9E7|169|
|ZTS|ZTS.N|Zoetis|20240101-2024|Contract Manufacturing|3.8E7|169|
|ZTS|ZTS.N|Zoetis|20240101-2024|Contract Manufacturing|2.0E7|169|
|ZTS|ZTS.N|Zoetis|20240101-2024|Pain and Sedation|1.94E8|169|
|ZTS|ZTS.N|Zoetis|20240101-2024|Other Non-Pharmaceutical|6.1E7|169|
|ZTS|ZTS.N|Zoetis|20240101-2024|Dermatology|3.63E8|169|
|ZTS|ZTS.N|Zoetis|20240101-2024|Other Pharmaceutical|1.56E8|169|
|ZTS|ZTS.N|Zoetis|20240101-2024|Anti-Infectives|2.81E8|169|
|ZTS|ZTS.N|Zoetis|20240101-2024|Contract Manufacturing|2.0E7|169|

|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|ZTS|ZTS.N|Zoetis|2023 Q4|13.695652173913043|5.23E8|169|
|ZTS|ZTS.N|Zoetis|2024 Q1|8.711433756805807|5.99E8|169|
|ZTS|ZTS.N|Zoetis|2024 Q2|-6.865671641791045|6.24E8|169|
|ZTS|ZTS.N|Zoetis|2024 Q3|16.10738255033557|6.92E8|169|